Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment.

Autor: Träger M; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Schweizer L; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany., Pérez E; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Schmid S; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hain EG; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Dittmayer C; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Onken J; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Fukuoka K; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan., Ichimura K; Division of Brain Tumor Translational Research, National Cancer Center Research Institute, Tokyo, Japan.; Department of Brain Disease Translational Research, Juntendo University Graduate School of Medicine, Tokyo, Japan., Schüller U; Institute of Neuropathology, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany., Dührsen L; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Müther M; Department of Neurosurgery, University Hospital Münster, Münster, Germany., Paulus W; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Thomas C; Institute of Neuropathology, University Hospital Münster, Münster, Germany., Gutt-Will M; Department of Neurosurgery, Inselspital, Bern University Hospital, Bern, Switzerland., Schucht P; Department of Neurosurgery, Inselspital, Bern University Hospital, Bern, Switzerland., Maragkou T; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Schittenhelm J; Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany., Eckert F; Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.; Department of Radiation Oncology, Medical University Vienna, AKH, Comprehensive Cancer Center, Vienna, Austria., Niyazi M; Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium (DKTK) partner site Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany., Fleischmann DF; Department of Radiation Oncology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Consortium (DKTK) partner site Munich, Munich, Germany., Dorostkar MM; Center for Neuropathology, Ludwig-Maximilians-University Munich, Munich, Germany., Feyer P; Department of Radiation Oncology, Vivantes Hospital Neukölln, Berlin, Germany., May SA; Department of Neurosurgery, Klinikum Chemnitz, Chemnitz, Germany., Moskopp D; Department of Neurosurgery, Vivantes Klinikum Im Friedrichshain, Berlin, Germany., Badakhshi H; Department of Clinical Radiation Oncology, Ernst Von Bergmann Medical Center Potsdam, Potsdam, Germany., Radke C; Department of Pathology, Ernst Von Bergmann Medical Center Potsdam, Potsdam, Germany., Walter J; Department of Neurosurgery, Jena University Hospital, Jena, Germany.; Department of Neurosurgery, Medical Center Saarbrücken, Saarbrücken, Germany., Ehret F; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Capper D; Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kaul D; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publikováno v: Neuro-oncology [Neuro Oncol] 2023 Jul 06; Vol. 25 (7), pp. 1286-1298.

Development and early diagnosis of critical illness myopathy in COVID-19 associated acute respiratory distress syndrome.

Autor: Rodriguez B; Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Branca M; CTU Bern, University of Bern, Bern, Switzerland., Gutt-Will M; Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Roth M; Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Söll N; Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Nansoz S; Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Cameron DR; Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Tankisi H; Department of Clinical Neurophysiology, Aarhus University Hospital & Dept of Clinical Medicine, Aarhus University, Aarhus, Denmark., Tan SV; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, London, UK., Bostock H; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK., Raabe A; Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Schefold JC; Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Jakob SM; Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Z'Graggen WJ; Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Publikováno v: Journal of cachexia, sarcopenia and muscle [J Cachexia Sarcopenia Muscle] 2022 Jun; Vol. 13 (3), pp. 1883-1895. Date of Electronic Publication: 2022 Apr 05.

TERT Promoter Mutation Analysis to Distinguish Glioma From Gliosis.

Autor: Hewer E; Institute of Pathology., Phour J; Institute of Pathology., Gutt-Will M; Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Schucht P; Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Dettmer MS; Institute of Pathology., Vassella E; Institute of Pathology.

Publikováno v: Journal of neuropathology and experimental neurology [J Neuropathol Exp Neurol] 2020 Apr 01; Vol. 79 (4), pp. 430-436.

Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting.

Autor: Hewer E; Institute of Pathology, University of Bern, Murtenstrasse 31, 3010, Bern, Switzerland. ekkehard.hewer@pathology.unibe.ch., Prebil N; Institute of Pathology, University of Bern, Murtenstrasse 31, 3010, Bern, Switzerland., Berezowska S; Institute of Pathology, University of Bern, Murtenstrasse 31, 3010, Bern, Switzerland., Gutt-Will M; Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland., Schucht P; Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland., Dettmer MS; Institute of Pathology, University of Bern, Murtenstrasse 31, 3010, Bern, Switzerland., Vassella E; Institute of Pathology, University of Bern, Murtenstrasse 31, 3010, Bern, Switzerland.

Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2017 Nov; Vol. 471 (5), pp. 641-649. Date of Electronic Publication: 2017 Aug 19.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.